National Heart, Lung, And Blood Institute; Notice of Closed Meetings, 59810-59811 [2022-21330]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
59810
Federal Register / Vol. 87, No. 190 / Monday, October 3, 2022 / Notices
Bethesda, MD 20892, (301) 594–0288,
dinoiaj2@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Analytics and Statistics for Population
Research Panel A Study Section.
Date: November 1–2, 2022.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victoriya Volkova, Ph.D.,
D.V.M., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 594–7781, volkovav2@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–19–
367: Maximizing Investigators’ Research
Award.
Date: November 1–2, 2022.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian Paul Chadwick,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–3586, chadwickbp@
csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Healthcare and Health Disparities Study
Section.
Date: November 2–3, 2022.
Time: 9 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tara Roshell Earl, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007C,
Bethesda, MD 20892, (301) 402–6857, earltr@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
22–008: NIH Faculty Institutional
Recruitment for Sustainable Transformation
(FIRST) Program: FIRST Cohort (U54).
Date: November 2–3, 2022.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Bellinger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
Bethesda, MD 20892, (301) 827–4446,
bellingerjd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; High-End
and Shared Instrumentation Grants.
Date: November 2–3, 2022.
VerDate Sep<11>2014
19:00 Sep 30, 2022
Jkt 259001
Time: 10 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan Arias, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170,
MSC 7840, Bethesda, MD 20892, 301–435–
2406, ariasj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Behavioral Neuroscience.
Date: November 2–3, 2022.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Simone Chebabo Weiner,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1011K,
Bethesda, MD 20892, (301) 435–1042,
weinersc@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Developmental Brain Disorders Study
Section.
Date: November 2–3, 2022.
Time: 10 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Pat Manos, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, (301) 408–
9866, manospa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Imaging, Surgery and
Bioengineering.
Date: November 2, 2022.
Time: 11 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Heidi B Friedman, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1012A,
MSC 7770, Bethesda, MD 20892, (301) 379–
5632, hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Dental and Craniofacial Biology.
Date: November 2, 2022.
Time: 1 p.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Srikanth Ranganathan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Health, 6701 Rockledge Drive, Room 4214,
MSC 7802, Bethesda, MD 20892, (301) 435–
1787, srikanth.ranganathan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 28, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–21384 Filed 9–30–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, And Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Contract Review Meeting 1.
Date: November 1, 2022.
Time: 9 a.m. to 2:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D.,
M.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 205–
J, Bethesda, MD 20892, (301) 827–7085,
zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Scientific Opportunities for Exploratory
Research (R21).
Date: November 1, 2022.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 7605
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Kazuyo Kegan, Ph.D.,
Scientific Review Officer, Office of Scientific
E:\FR\FM\03OCN1.SGM
03OCN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 190 / Monday, October 3, 2022 / Notices
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 208–T,
Bethesda, MD 20892, (301) 402–1334,
kazuyo.kegan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Contract Review Meeting 2.
Date: November 1, 2022.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D.,
M.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 205–
J, Bethesda, MD 20892, (301) 827–7085,
zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Research Education Program to Enhance
Diversity.
Date: November 2, 2022.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Shelley Sehnert, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Suite 208–T,
Bethesda, MD 20817, (301) 827–7984,
ssehnert@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Contract Review.
Date: November 7, 2022.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Manoj Kumar
Valiyaveettil, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA,
National Heart, Lung, and Blood Institute,
National Institutes of Health, 6705 Rockledge
Drive, Room 208–R, Bethesda, MD 20817,
(301) 402–1616, manoj.valiyaveettil@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Catalyze: Product Definition.
Date: November 9, 2022.
Time: 10 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Kristin Goltry, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 209–B,
Bethesda, MD 20892, (301) 435–0297,
goltrykl@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
VerDate Sep<11>2014
19:00 Sep 30, 2022
Jkt 259001
ARDS, Pneumonia, and Sepsis Phenotyping
Consortium.
Date: November 14–15, 2022.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, National Institutes
of Health, 6705 Rockledge Drive, Room 208–
Z, Bethesda, MD 20892, (301) 827–7987,
susan.sunnarborg@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Catalyze: Product Definition.
Date: November 15, 2022.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6705
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Manoj K. Valiyaveettil,
Ph.D., Scientific Review Officer, Blood &
Vascular Branch, Office Scientific Review,
Division of Extramural Research Activities
(DERA), National Institute of Health,
National Heart, Lung, and Blood Institute,
Bethesda, MD 20817, (301) 402–1616,
manoj.valiyaveettil@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 27, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–21330 Filed 9–30–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Office of AIDS Research
Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will be videocast and can be accessed
from the NIH Videocasting and
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
59811
Podcasting website (https://
videocast.nih.gov/).
Name of Committee: Office of AIDS
Research Advisory Council.
Date: October 27, 2022.
Time: 12 p.m. to 4:30 p.m.
Agenda: The sixty-first meeting of the
Office of AIDS Research Advisory Council
(OARAC) will include the OAR Director’s
Report; presentation and discussions from
PEPFAR, the U.S. Military HIV Research
Program, NIH-wide programs and initiatives;
updates from the Clinical Guidelines
Working Groups of OARAC; updates from
NIH HIV-related advisory councils; and
public comment.
Place: Office of AIDS Research, National
Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: CAPT Mary Glenshaw,
Ph.D., MPH, Corette Byrd, BSN, RN, Office of
AIDS Research, Office of the Director,
National Institutes of Health, 5601 Fisher’s
Lane, Room 2E61, Rockville, MD 20892,
(301) 496–0357, OARACinfo@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.oar.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: September 27, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–21331 Filed 9–30–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of HHS-Certified
Laboratories and Instrumented Initial
Testing Facilities Which Meet Minimum
Standards To Engage in Urine and Oral
Fluid Drug Testing for Federal
Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
AGENCY:
E:\FR\FM\03OCN1.SGM
03OCN1
]]>Agencies
[Federal Register Volume 87, Number 190 (Monday, October 3, 2022)]
[Notices]
[Pages 59810-59811]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21330]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, And Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Contract Review Meeting 1.
Date: November 1, 2022.
Time: 9 a.m. to 2:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., M.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Scientific Opportunities for Exploratory
Research (R21).
Date: November 1, 2022.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 7605 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Kazuyo Kegan, Ph.D., Scientific Review Officer,
Office of Scientific
[[Page 59811]]
Review/DERA, National Heart, Lung, and Blood Institute, National
Institutes of Health, 6705 Rockledge Drive, Room 208-T, Bethesda, MD
20892, (301) 402-1334, [email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Contract Review Meeting 2.
Date: November 1, 2022.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., M.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Research Education Program to Enhance
Diversity.
Date: November 2, 2022.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Shelley Sehnert, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Suite 208-T, Bethesda, MD 20817, (301) 827-7984,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Contract Review.
Date: November 7, 2022.
Time: 10 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Health, Rockledge I, 6705 Rockledge
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manoj Kumar Valiyaveettil, Ph.D., Scientific
Review Officer, Office of Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208-R, Bethesda, MD 20817, (301) 402-1616,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Catalyze: Product Definition.
Date: November 9, 2022.
Time: 10 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Kristin Goltry, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 209-B, Bethesda, MD 20892, (301) 435-0297,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; ARDS, Pneumonia, and Sepsis Phenotyping
Consortium.
Date: November 14-15, 2022.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific
Review Officer, Office of Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208-Z, Bethesda, MD 20892, (301) 827-7987,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Catalyze: Product Definition.
Date: November 15, 2022.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6705 Rockledge Drive,
Bethesda, MD 20817 (Virtual Meeting).
Contact Person: Manoj K. Valiyaveettil, Ph.D., Scientific Review
Officer, Blood & Vascular Branch, Office Scientific Review, Division
of Extramural Research Activities (DERA), National Institute of
Health, National Heart, Lung, and Blood Institute, Bethesda, MD
20817, (301) 402-1616, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 27, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-21330 Filed 9-30-22; 8:45 am]
BILLING CODE 4140-01-P
